$1.75
-0.055-3.06%
Last update: Aug 24, 10:08 AM
Organogenesis Holdings Inc Earnings Estimates
ORGONASDAQ
Organogenesis Holdings Earnings Estimates, EPS & Revenue | NASDAQ:ORGO
Organogenesis Holdings (ORGO) is scheduled to report Q3 earnings on November 5, 2026. Analysts estimate EPS of $-0.17 and quarterly revenue of $52.11M.
In the most recent quarter (Q2), Organogenesis Holdings reported EPS of $-0.69, missing estimates of $-0.35 by 0.97%. Revenue came in at $100.78M, exceeding the estimate of $54.27M by 0.86%.
Organogenesis Holdings has missed EPS estimates in 2 consecutive quarters.
Over the last 4 quarters, Organogenesis Holdings has averaged an EPS surprise of 0.89% and a revenue surprise of 0.36%.
Earnings Date
Nov 5
EPS Estimate
$-0.170
Quarterly Revenue Estimate
$52.11M
Annual Revenue
$454.61M
as of Jun 30
Organogenesis Holdings Earnings History
Analyze the earnings history of Organogenesis Holdings using advanced sorting and filters.
Organogenesis Holdings (ORGO) Earnings Per Share
The chart below shows Organogenesis Holdings's reported EPS compared to analyst estimates over recent quarters.
Organogenesis Holdings (ORGO) Revenue
The chart below shows Organogenesis Holdings's reported revenue compared to analyst estimates over recent quarters.
FAQ
When is Organogenesis Holdings (NASDAQ:ORGO) reporting earnings?
Organogenesis Holdings (ORGO) is scheduled to report earnings on November 5, 2026. The last reported earnings were for reported on August 6, 2026 for Q2.
What were the latest earnings per share (EPS) for Organogenesis Holdings (NASDAQ:ORGO)?
The Actual EPS was $-0.69, which missed the estimate of $-0.35.
What were Organogenesis Holdings’s (NASDAQ:ORGO) revenues?
The Actual Revenue was $100.78M, which beat the estimate of $54.27M.
